白血病抑制因子受体在癌症癌症中的作用
Wei Ma1, Haixu Yan2, Haoyuan Ma2
1School of Stomatology, China Medical University, Shenyang, China.
International journal of cancer
|September 16, 2024
概括
白血病抑制因子受体 (LIFR) 在癌症中起着复杂的作用,影响瘤生长和扩散. 其多样化的效应突出显示了LIFR作为新型癌症治疗的潜在目标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞信号传递 细胞信号传递
背景情况:
- 白血病抑制因子受体 (LIFR),与gp130复合,是白血病抑制因子 (LIF) 的受体,是一种多功能细胞因子.
- LIF/LIFR信号影响瘤细胞的增殖,亡,迁移和入侵.
- 癌症中LIFR的作用取决于情境,在不同的瘤类型和组织中具有不同的影响.
研究的目的:
- 审查LIFR启动的信号通道.
- 总结目前关于LIFR在人类癌症中的作用的文献.
- 探索LIFR在癌症治疗中的治疗潜力.
主要方法:
- 对LIFR信号和癌症研究的文献综述.
- 对LIFR在各种瘤相关过程中的功能进行分析.
- 评估LIFR的表达和治疗影响.
主要成果:
- LIFR激活了像JAK/STAT3.3这样的信号通路.
- 根据细胞背景,LIF/LIFR信号可以促进或抑制瘤的进展.
- 在许多癌细胞中观察到异常的LIFR表达.
结论:
- 在瘤发生过程中LIFR的双重作用需要仔细考虑治疗策略.
- 在开发新的癌症疗法方面,LIFR是一个有前途的目标.
- 了解LIFR信号对于癌症治疗和预后至关重要.
相关概念视频
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K


